Erythropoietin: from erythropoiesis to cardioprotection
Many of the drugs that has shown promise in the treatment of hematologic malignancies and solid tumors, associated with a high potential cardiotoxic. Within this group stand anthracyclines, identified as the type of chemotherapy most likely to cause heart damage, short or long term. With the improve...
Saved in:
Main Authors: | Liermis Michael Dita Salabert, Ivis Mendoza Hernández, Rafael Alejandro Gómez Baute, Elena García López, Lázaro E. de la Cruz Avilés, Aramis Núñez Quintana |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos
2010-08-01
|
Series: | Medisur |
Subjects: | |
Online Access: | http://medisur.sld.cu/index.php/medisur/article/view/1159 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
by: Rafael Alejandro Gómez Baute, et al.
Published: (2010-07-01) -
Marcadores morfológicos de hipoxia en el riñón fetal con insuficiencia placentaria tratado con neuro-EPO: estudio en ratas
by: Nínive Nuñez López, et al.
Published: (2020-02-01) -
Efectos fisiopatológicos del tabaquismo como factor de riesgo en la enfermedad periodontal
by: Maricel Castellanos González, et al.
Published: (2016-05-01) -
Anthracyclines and Acquired Long QT Syndrome. A Case Report
by: Carlos Rodríguez Armada, et al.
Published: (2014-12-01) -
Chemotherapy and radiotherapy’s toxicity prediction in the surgical cancer patient
by: Juan Carlos Arranz Pozo, et al.
Published: (2023-10-01)